Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 17490543 | HLA MATCHED (HLA-MATCHED) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| the aim of study was to investigate the pharmacokinetics and distribution of antithymocyte globulin (atg) in recipients of partially hla-matched hematopoietic stem cell transplantation. | |||||||
| 17490543 | HLA MATCHED (HLA-MATCHED) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| fifteen patients with hematological disorders were received hematopoietic stem cell transplantation from partially hla-matched related donor between october 2003 and october 2004 in the institute of hematology and people hospital, peking university. | |||||||
| 17490543 | HLA MATCHED (HLA-MATCHED) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| it is concluded that the conditioning regimen containing the dosage of 10 mg/kg of atg is effective and safely in recipients of partially hla-matched hematopoietic stem cell transplantation. | |||||||
| 17530001 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hematopoietic stem cell transplantation | Chinese | NA | NA | unclassified | |
| the success of allogeneic hematopoietic stem cell transplantation depends in part on the accuracy of human leukocyte antigen (hla) matching between the donor-recipient pair. | |||||||
| 17650670 | HLA MISMATCHED (HLA-MISMATCHED) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| to explore the influence factors of reconstitution of killer cell immunoglobulin-like receptor (kir) on nk cells in the early stage after non-t cells depletion (non-tcd) hla-mismatched hematopoietic stem cell transplantation (hsct). | |||||||
| 17663825 | HLA (HLA) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| [a clinical study of 31 patients with malignant hematopoietic disease treated with non-t cell-depleted hla-haploidentical hematopoietic stem cell transplantation]. | |||||||
| 17663825 | HLA (HLA) | hematopoietic stem cell transplantation | NA | NA | NA | only_studied | |
| to investigate the effects and prognosis of malignant hematological disease after hla haploidentical hematopoietic stem cell transplantation (h-hsct) without t-cell depletion. | |||||||
| 17663825 | HLA (HLA) | hematological disease | NA | NA | NA | only_studied | |
| to investigate the effects and prognosis of malignant hematological disease after hla haploidentical hematopoietic stem cell transplantation (h-hsct) without t-cell depletion. | |||||||
| 17663825 | HLA-A (HLA-A) | hematological disease | NA | NA | NA | unclassified | |
| hla h-hsct is an effective therapeutic method for malignant hematological disease, cd(3)(+) t cells count of the graft and the disparity of hla-a, b, dr loci are the major factors of impact on acute gvhd. | |||||||
| 17663825 | HLA-DR (HLA-DR) | hematological disease | NA | NA | NA | unclassified | |
| hla h-hsct is an effective therapeutic method for malignant hematological disease, cd(3)(+) t cells count of the graft and the disparity of hla-a, b, dr loci are the major factors of impact on acute gvhd. | |||||||
Copyright 2024